A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
Boston-based biotech Avalyn Pharma is the latest to hop on the IPO train, filing to list on the Nasdaq and raise funds for ...
Pulmonary Fibrosis NI has received a donation of €1,210 made in memory of the late Bart Teague. The cheque was presented by ...
Pulmonary Fibrosis NI has received a donation of €1,210 made in memory of the late Bart Teague. The cheque was presented by ...
A new inhaled therapy targets ANGPTL4 to reduce lung inflammation, fluid buildup, and scarring after infections. Preclinical ...
Nerandomilast may represent a meaningful addition to the treatment arsenal, offering patients and clinicians a new option for pulmonary fibrosis. A new systematic review and meta-analysis suggests ...
Nanyang Technological University, Singapore (NTU Singapore) is working with China’s Southern University of Science and ...
Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB ...
Damien Chua, PhD student; Liu Yu Xuan, Research Associate; Joseph Kim, PhD student; Cheng Hong Sheng, Senior Research Fellow; and ...
The Pulmonary Fibrosis Foundation (PFF) today announced its PFF Walk 2026 schedule as the organization celebrates the 10 (th) season of the national fundraising program, which has raised more than $7.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results